Molecular analysis of the multidrug transporter, P-glycoprotein

U A Germann1, T C Chambers

  • 1Vertex Pharmaceuticals Incorporated, 130 Waverly Street, Cambridge, MA, 02139-4242, U.S.A., Germann@macnet.vpharm.com.

Cytotechnology
|November 13, 2008
PubMed

Insights

Tumor cells can resist chemotherapy due to multidrug resistance (MDR), often involving P-glycoprotein. This protein acts as an ATP-dependent efflux pump, reducing drug accumulation and limiting cancer treatment success.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Cell Biology

Background:

  • Acquired or inherent resistance in tumor cells to cytotoxic drugs hinders effective cancer chemotherapy.
  • Multidrug resistance (MDR) is a significant challenge, characterized by simultaneous resistance to various anti-cancer drugs.
  • The human MDR1 gene product, P-glycoprotein, has been identified as a key mechanism contributing to MDR.

Purpose of the Study:

  • To review the current understanding of P-glycoprotein's structure and function in multidrug resistance.
  • To elucidate the molecular mechanisms underlying P-glycoprotein's role as an ATP-dependent drug efflux pump.
  • To explore P-glycoprotein's potential roles beyond drug transport, including ion and lipid transport and cholesterol biosynthesis.

Main Methods:

  • Analysis of drug-selected tumor cells to identify resistance mechanisms.
  • Structure-function studies utilizing cell biological, molecular genetic, and biochemical approaches.
  • Review of existing literature on P-glycoprotein's domain organization, topology, and activity.

Main Results:

  • P-glycoprotein, a 170 kDa N-glycosylated plasma membrane protein, is overexpressed in resistant cells, leading to reduced drug accumulation.
  • P-glycoprotein functions as an ATP-dependent efflux pump, characteristic of the ATP-binding cassette (ABC) transporter superfamily.
  • Studies have investigated drug and ATP binding sites, ATPase and transport activities, and potential roles in ion/lipid transport and phosphorylation effects.

Conclusions:

  • P-glycoprotein is a critical factor in multidrug resistance, significantly impacting cancer chemotherapy outcomes.
  • Understanding P-glycoprotein's structure and function is essential for developing strategies to overcome drug resistance.
  • Further research into P-glycoprotein's diverse functions may reveal new therapeutic targets for cancer treatment.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
The Significance of Membrane Transport01:44

The Significance of Membrane Transport

The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...